Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Gasser

Showing results (341-350 of 421) with videos related to

Pageof 43
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2018
Movement disorder society criteria for clinically established early Parkinson's diseaseDaniela Berg, Charles H Adler, Bastiaan R Bloem, et al.
Molecular Neurobiology|November 24, 2016
Genome-Wide Association Analysis of the Sense of Smell in U.S. Older Adults: Identification of Novel Risk Loci in African-Americans and European-AmericansJing Dong, Annah Wyss, Jingyun Yang, et al.
Plos One|August 23, 2013
Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locusDaniah Trabzuni, Mina Ryten, Warren Emmett, et al.
The Journal of Clinical Investigation|May 3, 2008
GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leakYvonne G Weber, Alexander Storch, Thomas V Wuttke, et al.
Neuroepidemiology|November 10, 2011
Parkinson's disease and dementia: a longitudinal study (DEMPARK)Monika Balzer-Geldsetzer, Ana Sofia Ferreira Braga da Costa, Martin Kronenbürger, et al.
Science Translational Medicine|May 27, 2026
The PET tracer [<sup>11</sup>C]MODAG-005 targets alpha-synuclein aggregates in the brainRan Sing Saw, Sabrina Haas, Felix Schmidt, et al.
Journal of Neurology|September 10, 2024
GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA)Sabrina Katzdobler, Georg Nübling, Martin Klietz, et al.
Nature|October 9, 2024
Overconfidence in climate overshootCarl-Friedrich Schleussner, Gaurav Ganti, Quentin Lejeune, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2009
Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial)Richard Dodel, Annika Spottke, Alexander Gerhard, et al.
Cell Systems|January 30, 2017
Genome-Scale Networks Link Neurodegenerative Disease Genes to α-Synuclein through Specific Molecular PathwaysVikram Khurana, Jian Peng, Chee Yeun Chung, et al.
Pageof 43

Showing results (341-350 of 421) with videos related to

Sort By:
Pageof 43
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2018
Movement disorder society criteria for clinically established early Parkinson's diseaseDaniela Berg, Charles H Adler, Bastiaan R Bloem, et al.
Molecular Neurobiology|November 24, 2016
Genome-Wide Association Analysis of the Sense of Smell in U.S. Older Adults: Identification of Novel Risk Loci in African-Americans and European-AmericansJing Dong, Annah Wyss, Jingyun Yang, et al.
Plos One|August 23, 2013
Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locusDaniah Trabzuni, Mina Ryten, Warren Emmett, et al.
The Journal of Clinical Investigation|May 3, 2008
GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leakYvonne G Weber, Alexander Storch, Thomas V Wuttke, et al.
Neuroepidemiology|November 10, 2011
Parkinson's disease and dementia: a longitudinal study (DEMPARK)Monika Balzer-Geldsetzer, Ana Sofia Ferreira Braga da Costa, Martin Kronenbürger, et al.
Science Translational Medicine|May 27, 2026
The PET tracer [<sup>11</sup>C]MODAG-005 targets alpha-synuclein aggregates in the brainRan Sing Saw, Sabrina Haas, Felix Schmidt, et al.
Journal of Neurology|September 10, 2024
GFAP and NfL as fluid biomarkers for clinical disease severity and disease progression in multiple system atrophy (MSA)Sabrina Katzdobler, Georg Nübling, Martin Klietz, et al.
Nature|October 9, 2024
Overconfidence in climate overshootCarl-Friedrich Schleussner, Gaurav Ganti, Quentin Lejeune, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2009
Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial)Richard Dodel, Annika Spottke, Alexander Gerhard, et al.
Cell Systems|January 30, 2017
Genome-Scale Networks Link Neurodegenerative Disease Genes to α-Synuclein through Specific Molecular PathwaysVikram Khurana, Jian Peng, Chee Yeun Chung, et al.
Pageof 43